Shared First Interchangeable Biosimilar Exclusivity May Be Allowed Under US FDA User Fee Bill

 
• By Derrick Gingery

Legislation in development also could create an option for tentative approval of interchangeable biosimilars.

shared biosimilar exclusivity
Sponsors may be confused by the statutory language governing first interchangeable exclusivity and whether multiple first filers could share it. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

More from Biosimilars

More from Biosimilars & Generics